| Outgoing Relation(s) |
| secondary amino compound (CHEBI:50995) is a organic amino compound (CHEBI:50047) |
| Incoming Relation(s) |
| (+)-minovincinine (CHEBI:145195) is a secondary amino compound (CHEBI:50995) |
| (R)-DRF053 (CHEBI:142838) is a secondary amino compound (CHEBI:50995) |
| (S,S)-2,5-di-(p-hydroxybenzyl)piperazine (CHEBI:145895) is a secondary amino compound (CHEBI:50995) |
| (S)-(+)-4-(5-carboxypentyl)methamphetamine (CHEBI:67238) is a secondary amino compound (CHEBI:50995) |
| (−)-N6-(2-phenylisopropyl)adenosine (CHEBI:192091) is a secondary amino compound (CHEBI:50995) |
| (−)-demecolcine (CHEBI:4393) is a secondary amino compound (CHEBI:50995) |
| (−)-FR901483 (CHEBI:207346) is a secondary amino compound (CHEBI:50995) |
| (−)-minovincinine (CHEBI:6941) is a secondary amino compound (CHEBI:50995) |
| (−)-vincadifformine (CHEBI:70507) is a secondary amino compound (CHEBI:50995) |
| (1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin (CHEBI:64117) is a secondary amino compound (CHEBI:50995) |
| (2-Methylpropyl)(propyl)amine (CHEBI:184419) is a secondary amino compound (CHEBI:50995) |
| (2R,3S,2'R)-nadolol (CHEBI:60917) is a secondary amino compound (CHEBI:50995) |
| (2R,3S,2'S)-nadolol (CHEBI:60922) is a secondary amino compound (CHEBI:50995) |
| (2S,3R,2'R)-nadolol (CHEBI:60920) is a secondary amino compound (CHEBI:50995) |
| (2S,3R,2'S)-nadolol (CHEBI:60918) is a secondary amino compound (CHEBI:50995) |
| {2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl}methanol (CHEBI:78416) is a secondary amino compound (CHEBI:50995) |
| ent-pavettamine (CHEBI:178110) is a secondary amino compound (CHEBI:50995) |
| N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide (CHEBI:64217) is a secondary amino compound (CHEBI:50995) |
| N-(1-benzylpiperidin-4-yl)-2-(pyridin-3-yl)quinazolin-4-amine (CHEBI:121832) is a secondary amino compound (CHEBI:50995) |
| N-(1-benzylpyrrolidin-3-yl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine (CHEBI:145528) is a secondary amino compound (CHEBI:50995) |
| N-(2-[(2-aminoethyl)(methyl)amino]-5-{[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}phenyl)acetamide (CHEBI:143115) is a secondary amino compound (CHEBI:50995) |
| N-(2-{[(2R)-1-phenylpropan-2-yl]amino}ethyl)lysinamide (CHEBI:233671) is a secondary amino compound (CHEBI:50995) |
| N-(2-aminoethyl)-1-aziridine-ethanamine (CHEBI:145998) is a secondary amino compound (CHEBI:50995) |
| N-(2-hydroxyethyl)-β-alanine (CHEBI:141390) is a secondary amino compound (CHEBI:50995) |
| N-(2-methoxyethyl)-4-{[6-(pyridin-4-yl)quinazolin-2-yl]amino}benzamide (CHEBI:143119) is a secondary amino compound (CHEBI:50995) |
| N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine (CHEBI:64098) is a secondary amino compound (CHEBI:50995) |
| N-(2,6-dimethylindan-1-yl)-6-(1-fluoroethyl)-1,3,5-triazine-2,4-diamine (CHEBI:133240) is a secondary amino compound (CHEBI:50995) |
| N-(3-{[2-(2-fluorophenyl)quinazolin-4-yl]amino}phenyl)acetamide (CHEBI:105960) is a secondary amino compound (CHEBI:50995) |
| N-(3-fluorophenyl)-2-(pyridin-4-yl)quinazolin-4-amine (CHEBI:94208) is a secondary amino compound (CHEBI:50995) |
| N-(3-methoxyphenyl)quinazolin-4-amine (CHEBI:103948) is a secondary amino compound (CHEBI:50995) |
| N-(4-methylphenyl)-2-(pyridin-4-yl)quinazolin-4-amine (CHEBI:107761) is a secondary amino compound (CHEBI:50995) |
| N-(4-nitrophenyl)-3-oxovalidamine (CHEBI:15984) is a secondary amino compound (CHEBI:50995) |
| N-[1-(3,5-dimethylphenoxy)propan-2-yl]-6-(2-fluoropropan-2-yl)-1,3,5-triazine-2,4-diamine (CHEBI:143897) is a secondary amino compound (CHEBI:50995) |
| N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide (CHEBI:47495) is a secondary amino compound (CHEBI:50995) |
| N-[2-chloro-2-(naphthalen-2-yl)ethyl]propan-2-amine (CHEBI:232040) is a secondary amino compound (CHEBI:50995) |
| N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide (CHEBI:63082) is a secondary amino compound (CHEBI:50995) |
| N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide (CHEBI:82857) is a secondary amino compound (CHEBI:50995) |
| N-{2'-[(4-fluorophenyl)amino]-4,4'-bipyridin-2-yl}-4-methoxycyclohexanecarboxamide (CHEBI:43460) is a secondary amino compound (CHEBI:50995) |
| N-{3-[(2-phenylquinazolin-4-yl)amino]phenyl}acetamide (CHEBI:113063) is a secondary amino compound (CHEBI:50995) |
| N-{4-[(2S)-2-(methylamino)propyl]phenyl}-6-sulfanylhexanamide (CHEBI:233627) is a secondary amino compound (CHEBI:50995) |
| N-{4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine (CHEBI:102167) is a secondary amino compound (CHEBI:50995) |
| N-benzylquinazolin-4-amine (CHEBI:92768) is a secondary amino compound (CHEBI:50995) |
| N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydropyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide (CHEBI:82714) is a secondary amino compound (CHEBI:50995) |
| N-desmethylvenlafaxine (CHEBI:83525) is a secondary amino compound (CHEBI:50995) |
| N-ethylasparagine (CHEBI:64308) is a secondary amino compound (CHEBI:50995) |
| N-methyl-D-aspartic acid (CHEBI:31882) is a secondary amino compound (CHEBI:50995) |
| N-methyl-1-(5-pyridin-3-ylfuran-2-yl)methanamine (CHEBI:41755) is a secondary amino compound (CHEBI:50995) |
| N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine (CHEBI:86990) is a secondary amino compound (CHEBI:50995) |
| N-methyl-β-alanine (CHEBI:138669) is a secondary amino compound (CHEBI:50995) |
| N-methylglucamine (CHEBI:59732) is a secondary amino compound (CHEBI:50995) |
| N-methylleucine (CHEBI:43983) is a secondary amino compound (CHEBI:50995) |
| N-methylmescaline (CHEBI:7319) is a secondary amino compound (CHEBI:50995) |
| N-pyrazin-2-yl-N2-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide (CHEBI:143875) is a secondary amino compound (CHEBI:50995) |
| N,N'-[disulfanediyldi(ethane-2,1-diyl)]bis[2-(1H-indol-3-yl)ethan-1-amine] (CHEBI:143872) is a secondary amino compound (CHEBI:50995) |
| N,N'-bis(diphenylmethyl)ethane-1,2-diamine (CHEBI:92409) is a secondary amino compound (CHEBI:50995) |
| N,N'-diphenyl-1,4-phenylenediamine (CHEBI:34860) is a secondary amino compound (CHEBI:50995) |
| N,O-didesmethylvenlafaxine (CHEBI:83529) is a secondary amino compound (CHEBI:50995) |
| N,O-dimethyltyramine (CHEBI:75143) is a secondary amino compound (CHEBI:50995) |
| N1,N12-diethylspermine (CHEBI:90282) is a secondary amino compound (CHEBI:50995) |
| N1,N8-bis-(dihydrocaffeoyl)spermidine (CHEBI:142881) is a secondary amino compound (CHEBI:50995) |
| N1,N8-bis(caffeoyl)spermidine (CHEBI:138028) is a secondary amino compound (CHEBI:50995) |
| N1,N8-bis(coumaroyl)spermidine (CHEBI:85530) is a secondary amino compound (CHEBI:50995) |
| N1,N8-bis(sinapoyl)-spermidine (CHEBI:85300) is a secondary amino compound (CHEBI:50995) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a secondary amino compound (CHEBI:50995) |
| N2-methylguanine (CHEBI:21818) is a secondary amino compound (CHEBI:50995) |
| N4-{2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl}pentane-1,4-diamine (CHEBI:141487) is a secondary amino compound (CHEBI:50995) |
| N6-(6-aminohexyl)-cAMP (CHEBI:84606) is a secondary amino compound (CHEBI:50995) |
| p-aminodiphenylamine (CHEBI:59038) is a secondary amino compound (CHEBI:50995) |
| D-lysyl-N-(2-{[(2R)-1-phenylpropan-2-yl]amino}ethyl)glycinamide (CHEBI:233672) is a secondary amino compound (CHEBI:50995) |
| D-nopaline (CHEBI:17249) is a secondary amino compound (CHEBI:50995) |
| D-octopine (CHEBI:15805) is a secondary amino compound (CHEBI:50995) |
| L-BMAA (CHEBI:73169) is a secondary amino compound (CHEBI:50995) |
| 1-(tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl benzoate (CHEBI:143782) is a secondary amino compound (CHEBI:50995) |
| 1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine (CHEBI:132234) is a secondary amino compound (CHEBI:50995) |
| 1-(2-chlorophenyl)-2-isopropylaminoethanol (CHEBI:146226) is a secondary amino compound (CHEBI:50995) |
| 1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (CHEBI:77796) is a secondary amino compound (CHEBI:50995) |
| 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (CHEBI:195380) is a secondary amino compound (CHEBI:50995) |
| 1-(4-methoxyphenyl)-2-{[4-(4-nitrophenyl)butan-2-yl]amino}ethanol (CHEBI:144925) is a secondary amino compound (CHEBI:50995) |
| 1-[4-carboxy-2-(3-pentylamino)phenyl]-5,5-bis(hydroxymethyl)pyrrolidin-2-one (CHEBI:45265) is a secondary amino compound (CHEBI:50995) |
| 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-N-[4-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]-1,4-dihydroquinoline-3-carboxamide (CHEBI:156323) is a secondary amino compound (CHEBI:50995) |
| 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol (CHEBI:131801) is a secondary amino compound (CHEBI:50995) |
| 1,16-diamino-4,8,13-triazahexadecane (CHEBI:200882) is a secondary amino compound (CHEBI:50995) |
| 1,17-Diamino-4,9,13-triazaheptadecane (CHEBI:168529) is a secondary amino compound (CHEBI:50995) |
| 1,18-Diamino-5,9,14-triazaoctadecane (CHEBI:191840) is a secondary amino compound (CHEBI:50995) |
| 1,20-diamino-4,8,12,17-tetra-azaeicosane (CHEBI:227709) is a secondary amino compound (CHEBI:50995) |
| 1,20-diamino-4,8,13,17-tetra-azaeicosane (CHEBI:201367) is a secondary amino compound (CHEBI:50995) |
| 1,4,10,13-Tetraoxa-7,16-diazacyclooctadecane (CHEBI:230176) is a secondary amino compound (CHEBI:50995) |
| 10-hydroxycoronaridine (CHEBI:146256) is a secondary amino compound (CHEBI:50995) |
| 17-O-acetylnorajmaline (CHEBI:17384) is a secondary amino compound (CHEBI:50995) |
| 19-O-acetylhörhammericine (CHEBI:145333) is a secondary amino compound (CHEBI:50995) |
| 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(propan-2-yl)pentanenitrile (CHEBI:134080) is a secondary amino compound (CHEBI:50995) |
| 2-(6-aminohexylamino)-cAMP (CHEBI:84604) is a secondary amino compound (CHEBI:50995) |
| 2-(6-methylpyridin-2-yl)-N-(pyridin-4-yl)quinazolin-4-amine (CHEBI:143120) is a secondary amino compound (CHEBI:50995) |
| 2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol (CHEBI:64064) is a secondary amino compound (CHEBI:50995) |
| 2-(methylamino)acetaldehyde (CHEBI:169127) is a secondary amino compound (CHEBI:50995) |
| 2-{[2-(2-chlorophenyl)-2-hydroxyethyl]amino}-N-[(2-fluorophenyl)methyl]acetamide (CHEBI:143873) is a secondary amino compound (CHEBI:50995) |
| 2-benzylidene-3-(cyclohexylamino)indan-1-one (CHEBI:94321) is a secondary amino compound (CHEBI:50995) |
| 2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide (CHEBI:167638) is a secondary amino compound (CHEBI:50995) |
| 2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide (CHEBI:91331) is a secondary amino compound (CHEBI:50995) |
| 2-methylamino-1-phenylpropan-1-one (CHEBI:149677) is a secondary amino compound (CHEBI:50995) |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] (CHEBI:64019) is a secondary amino compound (CHEBI:50995) |
| 2,3,8,9-tetramethoxy-5,6,11,12-tetrahydro-5,11-epiminodibenzo[a,e][8]annulene (CHEBI:77051) is a secondary amino compound (CHEBI:50995) |
| 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinylbenzoquinone (CHEBI:90193) is a secondary amino compound (CHEBI:50995) |
| 2,5-dioxopyrrolidin-1-yl N-[(2S)-1-phenylpropan-2-yl]-β-alaninate (CHEBI:233674) is a secondary amino compound (CHEBI:50995) |
| 2,6-dihydroxypseudooxynicotine (CHEBI:28220) is a secondary amino compound (CHEBI:50995) |
| 3-(methylaminomethyl)indole (CHEBI:137310) is a secondary amino compound (CHEBI:50995) |
| 3-(phenethylamino)-butan-2-one (CHEBI:143030) is a secondary amino compound (CHEBI:50995) |
| 3-(phenethylamino)-butan-2-one(1+) (CHEBI:143110) is a secondary amino compound (CHEBI:50995) |
| 3-[(3-aminopropyl)amino]-4-hydroxybenzoic acid (CHEBI:142394) is a secondary amino compound (CHEBI:50995) |
| 3-[(4-anilinophenyl)diazenyl]benzene-1-sulfonic acid (CHEBI:87240) is a secondary amino compound (CHEBI:50995) |
| 3-[(4-bromophenyl)amino]-3-(4-methoxyphenyl)-1-phenylpropan-1-one (CHEBI:75350) is a secondary amino compound (CHEBI:50995) |
| 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid (CHEBI:143310) is a secondary amino compound (CHEBI:50995) |
| 3-epi-fagomine (CHEBI:132399) is a secondary amino compound (CHEBI:50995) |
| 3-chloro-N-[trans-4-(methylamino)cyclohexyl]-N-[3-(pyridin-4-yl)benzyl]-1-benzothiophene-2-carboxamide (CHEBI:138438) is a secondary amino compound (CHEBI:50995) |
| 3'-hydroxy-4'-methoxydiclofenac (CHEBI:223404) is a secondary amino compound (CHEBI:50995) |
| 3'-hydroxydiclofenac (CHEBI:223792) is a secondary amino compound (CHEBI:50995) |
| 4-({[2-(1H-imidazol-4-yl)ethyl]amino}methyl)benzoic acid (CHEBI:234472) is a secondary amino compound (CHEBI:50995) |
| 4-(1-hydroxy-2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)phenol (CHEBI:82647) is a secondary amino compound (CHEBI:50995) |
| 4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-N-(3-methoxyphenyl)pyrimidin-2-amine (CHEBI:143118) is a secondary amino compound (CHEBI:50995) |
| 4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-N-[3-(morpholin-4-yl)phenyl]pyrimidin-2-amine (CHEBI:144675) is a secondary amino compound (CHEBI:50995) |
| 4-(methylamino)antipyrine (CHEBI:73261) is a secondary amino compound (CHEBI:50995) |
| 4-[2-[[1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol (CHEBI:91775) is a secondary amino compound (CHEBI:50995) |
| 4-{2-[(2-hydroxybenzyl)amino]ethyl}-2,5-dimethoxybenzonitrile (CHEBI:145979) is a secondary amino compound (CHEBI:50995) |
| 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol (CHEBI:90529) is a secondary amino compound (CHEBI:50995) |
| 4-hydroxymethamphetamine (CHEBI:76833) is a secondary amino compound (CHEBI:50995) |
| 4-methyl-N-[3-(morpholin-4-yl)phenyl]-3-[3-(piperidin-4-yl)-1,2-benzoxazol-6-yl]benzamide (CHEBI:90542) is a secondary amino compound (CHEBI:50995) |
| 4'-hydroxy torasemide (CHEBI:155915) is a secondary amino compound (CHEBI:50995) |
| 4'-hydroxydiclofenac (CHEBI:59613) is a secondary amino compound (CHEBI:50995) |
| 4'-O-methylnorbelladine (CHEBI:80667) is a secondary amino compound (CHEBI:50995) |
| 4',5-dihydroxydiclofenac (CHEBI:223401) is a secondary amino compound (CHEBI:50995) |
| 5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide (CHEBI:142546) is a secondary amino compound (CHEBI:50995) |
| 5-(methylamino)-2-phenyl-4-[3-(trifluoromethyl)phenyl]furan-3(2H)-one (CHEBI:138738) is a secondary amino compound (CHEBI:50995) |
| 5-[(1-phenylcyclohexyl)amino]pentanoic acid (CHEBI:63596) is a secondary amino compound (CHEBI:50995) |
| 5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol (CHEBI:83329) is a secondary amino compound (CHEBI:50995) |
| 5-amino-1-anilinoimidazole-4-carbonitrile (CHEBI:134421) is a secondary amino compound (CHEBI:50995) |
| 5-chloro-N-{1-[4-(difluoromethoxy)phenyl]propyl}-6-methylpyrimidin-4-amine (CHEBI:82861) is a secondary amino compound (CHEBI:50995) |
| 5-hydroxydiclofenac (CHEBI:59612) is a secondary amino compound (CHEBI:50995) |
| 5,5,7,12,12,14-hexamethyl-1,4,8,11-tetrazacyclotetradecane (CHEBI:107967) is a secondary amino compound (CHEBI:50995) |
| 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate (CHEBI:4734) is a secondary amino compound (CHEBI:50995) |
| 6-{[(2S)-1-phenylpropan-2-yl]amino}hexane-1-thiol (CHEBI:233626) is a secondary amino compound (CHEBI:50995) |
| 6-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (CHEBI:170005) is a secondary amino compound (CHEBI:50995) |
| 6-hydroxypseudooxynicotine (CHEBI:37754) is a secondary amino compound (CHEBI:50995) |
| 6,8-difluoro-4-(pyridin-3-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline (CHEBI:139076) is a secondary amino compound (CHEBI:50995) |
| 7-nitrobenzoxadiazole-6-aminohexanoic acid (CHEBI:52162) is a secondary amino compound (CHEBI:50995) |
| 8-(6-aminohexylamino)-cAMP (CHEBI:84613) is a secondary amino compound (CHEBI:50995) |
| 8-demethyl-8-(methylamino)riboflavin (CHEBI:137340) is a secondary amino compound (CHEBI:50995) |
| 9-cyclopentyl-N8-(2-fluorophenyl)-N2-(4-methoxyphenyl)-9H-purine-2,8-diamine (CHEBI:90530) is a secondary amino compound (CHEBI:50995) |
| abediterol (CHEBI:142077) is a secondary amino compound (CHEBI:50995) |
| ABT-737 (CHEBI:47575) is a secondary amino compound (CHEBI:50995) |
| acebutolol (CHEBI:2379) is a secondary amino compound (CHEBI:50995) |
| aceclofenac (CHEBI:31159) is a secondary amino compound (CHEBI:50995) |
| acridine half-mustard (CHEBI:132980) is a secondary amino compound (CHEBI:50995) |
| acridine red 3B free base (CHEBI:90408) is a secondary amino compound (CHEBI:50995) |
| actinodaphnine (CHEBI:2444) is a secondary amino compound (CHEBI:50995) |
| adavosertib (CHEBI:91414) is a secondary amino compound (CHEBI:50995) |
| AKI00000020a (CHEBI:169940) is a secondary amino compound (CHEBI:50995) |
| alangimarckine (CHEBI:2536) is a secondary amino compound (CHEBI:50995) |
| albumycin (CHEBI:177358) is a secondary amino compound (CHEBI:50995) |
| albuterol (CHEBI:2549) is a secondary amino compound (CHEBI:50995) |
| alisertib (CHEBI:125628) is a secondary amino compound (CHEBI:50995) |
| alminoprofen (CHEBI:31190) is a secondary amino compound (CHEBI:50995) |
| alprenolol (CHEBI:51211) is a secondary amino compound (CHEBI:50995) |
| alvespimycin (CHEBI:65324) is a secondary amino compound (CHEBI:50995) |
| AMG-925 (CHEBI:145537) is a secondary amino compound (CHEBI:50995) |
| amineptine (CHEBI:32499) is a secondary amino compound (CHEBI:50995) |
| amocarzine (CHEBI:38946) is a secondary amino compound (CHEBI:50995) |
| amodiaquine (CHEBI:2674) is a secondary amino compound (CHEBI:50995) |
| amoscanate (CHEBI:38944) is a secondary amino compound (CHEBI:50995) |
| anilazine (CHEBI:82076) is a secondary amino compound (CHEBI:50995) |
| argatroban (CHEBI:48720) is a secondary amino compound (CHEBI:50995) |
| AS1842856 (CHEBI:145800) is a secondary amino compound (CHEBI:50995) |
| ASP-3026 (CHEBI:167650) is a secondary amino compound (CHEBI:50995) |
| atenolol acid (CHEBI:83478) is a secondary amino compound (CHEBI:50995) |
| atomoxetine (CHEBI:127342) is a secondary amino compound (CHEBI:50995) |
| AZ505 (CHEBI:228259) is a secondary amino compound (CHEBI:50995) |
| AZD-1152 (CHEBI:91367) is a secondary amino compound (CHEBI:50995) |
| AZD3463 (CHEBI:167653) is a secondary amino compound (CHEBI:50995) |
| AZD8186 (CHEBI:234358) is a secondary amino compound (CHEBI:50995) |
| AZT-1152 (CHEBI:167636) is a secondary amino compound (CHEBI:50995) |
| baeocystin (CHEBI:139505) is a secondary amino compound (CHEBI:50995) |
| BAM15 (CHEBI:233585) is a secondary amino compound (CHEBI:50995) |
| BCI-215 (CHEBI:143128) is a secondary amino compound (CHEBI:50995) |
| BDA-366 (CHEBI:86325) is a secondary amino compound (CHEBI:50995) |
| benzonatate (CHEBI:3032) is a secondary amino compound (CHEBI:50995) |
| Benzylhydrochlorothiazide (CHEBI:31269) is a secondary amino compound (CHEBI:50995) |
| betahistine (CHEBI:35677) is a secondary amino compound (CHEBI:50995) |
| BI-2536 (CHEBI:49868) is a secondary amino compound (CHEBI:50995) |
| BI-3406 (CHEBI:746963) is a secondary amino compound (CHEBI:50995) |
| binimetinib (CHEBI:145371) is a secondary amino compound (CHEBI:50995) |
| Bis-(2-decyloxy-ethyl)-amine (CHEBI:189266) is a secondary amino compound (CHEBI:50995) |
| Bis(2-ethylhexyl) amine (CHEBI:193588) is a secondary amino compound (CHEBI:50995) |
| bis(7)-tacrine (CHEBI:138435) is a secondary amino compound (CHEBI:50995) |
| bitolterol (CHEBI:3133) is a secondary amino compound (CHEBI:50995) |
| bupirimate (CHEBI:81952) is a secondary amino compound (CHEBI:50995) |
| bupropion (CHEBI:3219) is a secondary amino compound (CHEBI:50995) |
| cadabicine sulfate (CHEBI:132716) is a secondary amino compound (CHEBI:50995) |
| caldopentamine (CHEBI:83546) is a secondary amino compound (CHEBI:50995) |
| Canavalmine (CHEBI:191821) is a secondary amino compound (CHEBI:50995) |
| cangrelor (CHEBI:90841) is a secondary amino compound (CHEBI:50995) |
| carvedilol (CHEBI:3441) is a secondary amino compound (CHEBI:50995) |
| CBL0137 (CHEBI:138650) is a secondary amino compound (CHEBI:50995) |
| CD532 (CHEBI:83432) is a secondary amino compound (CHEBI:50995) |
| ceratamine A (CHEBI:65608) is a secondary amino compound (CHEBI:50995) |
| ceritinib (CHEBI:78432) is a secondary amino compound (CHEBI:50995) |
| CGP 12177 (CHEBI:73288) is a secondary amino compound (CHEBI:50995) |
| CGP 78608 (CHEBI:64061) is a secondary amino compound (CHEBI:50995) |
| CGP-54626 (CHEBI:232377) is a secondary amino compound (CHEBI:50995) |
| chanoclavine-I (CHEBI:3576) is a secondary amino compound (CHEBI:50995) |
| chanoclavine-I aldehyde (CHEBI:64429) is a secondary amino compound (CHEBI:50995) |
| CHIR 99021 (CHEBI:91091) is a secondary amino compound (CHEBI:50995) |
| CHIR-98014 (CHEBI:167657) is a secondary amino compound (CHEBI:50995) |
| chlordiazepoxide (CHEBI:3611) is a secondary amino compound (CHEBI:50995) |
| chloroquine (CHEBI:3638) is a secondary amino compound (CHEBI:50995) |
| chrysopine (CHEBI:83079) is a secondary amino compound (CHEBI:50995) |
| CHZ868 (CHEBI:90828) is a secondary amino compound (CHEBI:50995) |
| cinacalcet (CHEBI:48390) is a secondary amino compound (CHEBI:50995) |
| clenbuterol (CHEBI:174690) is a secondary amino compound (CHEBI:50995) |
| CM-272 (CHEBI:229970) is a secondary amino compound (CHEBI:50995) |
| cobimetinib (CHEBI:90851) is a secondary amino compound (CHEBI:50995) |
| coelenterazine dioxetanone (CHEBI:139324) is a secondary amino compound (CHEBI:50995) |
| coelenterazine h dioxetanone (CHEBI:138063) is a secondary amino compound (CHEBI:50995) |
| colterol (CHEBI:73085) is a secondary amino compound (CHEBI:50995) |
| CT-179 (CHEBI:234076) is a secondary amino compound (CHEBI:50995) |
| cyclopentamine (CHEBI:134766) is a secondary amino compound (CHEBI:50995) |
| cyprodinil (CHEBI:4045) is a secondary amino compound (CHEBI:50995) |
| cytisine (CHEBI:4055) is a secondary amino compound (CHEBI:50995) |
| CZC-25146 (CHEBI:78414) is a secondary amino compound (CHEBI:50995) |
| D617 (CHEBI:83528) is a secondary amino compound (CHEBI:50995) |
| dacomitinib (CHEBI:132268) is a secondary amino compound (CHEBI:50995) |
| dasatinib (anhydrous) (CHEBI:49375) is a secondary amino compound (CHEBI:50995) |
| DC_517 (CHEBI:229971) is a secondary amino compound (CHEBI:50995) |
| desipramine (CHEBI:47781) is a secondary amino compound (CHEBI:50995) |
| desmethyldoxepin (CHEBI:141547) is a secondary amino compound (CHEBI:50995) |
| desmethylranitidine (CHEBI:132051) is a secondary amino compound (CHEBI:50995) |
| dexpramipexole (CHEBI:232420) is a secondary amino compound (CHEBI:50995) |
| diclofenac (CHEBI:47381) is a secondary amino compound (CHEBI:50995) |
| diclofenac β-D-glucosiduronic acid (CHEBI:59609) is a secondary amino compound (CHEBI:50995) |
| diisopropanolamine (CHEBI:143266) is a secondary amino compound (CHEBI:50995) |
| dinaciclib (CHEBI:95060) is a secondary amino compound (CHEBI:50995) |
| diphenylamine (CHEBI:4640) is a secondary amino compound (CHEBI:50995) |
| dizocilpine (CHEBI:34725) is a secondary amino compound (CHEBI:50995) |
| DS16570511 (CHEBI:234042) is a secondary amino compound (CHEBI:50995) |
| Durazol blue 4R (acid form) (CHEBI:88284) is a secondary amino compound (CHEBI:50995) |
| dysidine (CHEBI:65816) is a secondary amino compound (CHEBI:50995) |
| dysiherbaine (CHEBI:197431) is a secondary amino compound (CHEBI:50995) |
| E3040 (CHEBI:4732) is a secondary amino compound (CHEBI:50995) |
| E3040 glucuronide (CHEBI:4733) is a secondary amino compound (CHEBI:50995) |
| elacestrant (CHEBI:229213) is a secondary amino compound (CHEBI:50995) |
| enasidenib (CHEBI:145374) is a secondary amino compound (CHEBI:50995) |
| entrectinib (CHEBI:195558) is a secondary amino compound (CHEBI:50995) |
| erdasporine A (CHEBI:156313) is a secondary amino compound (CHEBI:50995) |
| erdasporine B (CHEBI:156314) is a secondary amino compound (CHEBI:50995) |
| erdasporine C (CHEBI:156315) is a secondary amino compound (CHEBI:50995) |
| ergometrine (CHEBI:4822) is a secondary amino compound (CHEBI:50995) |
| erlotinib (CHEBI:114785) is a secondary amino compound (CHEBI:50995) |
| ethirimol (CHEBI:81989) is a secondary amino compound (CHEBI:50995) |
| ethyl 2-(methylamino)-1-phenylcyclohex-3-ene-1-carboxylate (CHEBI:77835) is a secondary amino compound (CHEBI:50995) |
| EVP4593 (CHEBI:232358) is a secondary amino compound (CHEBI:50995) |
| ezogabine (CHEBI:68584) is a secondary amino compound (CHEBI:50995) |
| fenamic acid (CHEBI:34756) is a secondary amino compound (CHEBI:50995) |
| fenfluramine (CHEBI:5000) is a secondary amino compound (CHEBI:50995) |
| fenoterol (CHEBI:149226) is a secondary amino compound (CHEBI:50995) |
| FFN206 (CHEBI:232373) is a secondary amino compound (CHEBI:50995) |
| finafloxacin (CHEBI:85176) is a secondary amino compound (CHEBI:50995) |
| florbetaben (18F) (CHEBI:79033) is a secondary amino compound (CHEBI:50995) |
| fluazinam (CHEBI:81843) is a secondary amino compound (CHEBI:50995) |
| flumatinib (CHEBI:233593) is a secondary amino compound (CHEBI:50995) |
| flutemetamol (18F) (CHEBI:76611) is a secondary amino compound (CHEBI:50995) |
| G-573 (CHEBI:83404) is a secondary amino compound (CHEBI:50995) |
| gardiquimod (CHEBI:234430) is a secondary amino compound (CHEBI:50995) |
| GDC-0623 (CHEBI:167659) is a secondary amino compound (CHEBI:50995) |
| gefitinib (CHEBI:49668) is a secondary amino compound (CHEBI:50995) |
| GGTI-2133 free base (CHEBI:101257) is a secondary amino compound (CHEBI:50995) |
| gilteritinib (CHEBI:145372) is a secondary amino compound (CHEBI:50995) |
| glafenine (CHEBI:31653) is a secondary amino compound (CHEBI:50995) |
| GNE-3511 (CHEBI:232381) is a secondary amino compound (CHEBI:50995) |
| GSK-J1 (CHEBI:131152) is a secondary amino compound (CHEBI:50995) |
| GSK-J4 (CHEBI:95077) is a secondary amino compound (CHEBI:50995) |
| GSK2879552 (CHEBI:176334) is a secondary amino compound (CHEBI:50995) |
| GSK3-XIII (CHEBI:78544) is a secondary amino compound (CHEBI:50995) |
| guvacine (CHEBI:5576) is a secondary amino compound (CHEBI:50995) |
| guvacoline (CHEBI:80754) is a secondary amino compound (CHEBI:50995) |
| herquline B (CHEBI:66012) is a secondary amino compound (CHEBI:50995) |
| herquline C (CHEBI:229729) is a secondary amino compound (CHEBI:50995) |
| HG-10-102-01 (CHEBI:132509) is a secondary amino compound (CHEBI:50995) |
| HG-9-91-01 (CHEBI:133818) is a secondary amino compound (CHEBI:50995) |
| Hoffman's violet free base (CHEBI:88207) is a secondary amino compound (CHEBI:50995) |
| hörhammericine (CHEBI:5765) is a secondary amino compound (CHEBI:50995) |
| HTH-01-015 (CHEBI:234378) is a secondary amino compound (CHEBI:50995) |
| hydroxy torasemide (CHEBI:155897) is a secondary amino compound (CHEBI:50995) |
| hydroxychloroquine (CHEBI:5801) is a secondary amino compound (CHEBI:50995) |
| ICI 118551 (CHEBI:73289) is a secondary amino compound (CHEBI:50995) |
| ICR 340 (free base) (CHEBI:189532) is a secondary amino compound (CHEBI:50995) |
| idelalisib (CHEBI:82701) is a secondary amino compound (CHEBI:50995) |
| IKK16 (CHEBI:92257) is a secondary amino compound (CHEBI:50995) |
| imidapril (CHEBI:135654) is a secondary amino compound (CHEBI:50995) |
| imidaprilat (CHEBI:141520) is a secondary amino compound (CHEBI:50995) |
| iminoctadine (CHEBI:5569) is a secondary amino compound (CHEBI:50995) |
| iminodiacetonitrile (CHEBI:71189) is a secondary amino compound (CHEBI:50995) |
| indacaterol (CHEBI:68575) is a secondary amino compound (CHEBI:50995) |
| indolmycin (CHEBI:79394) is a secondary amino compound (CHEBI:50995) |
| iodocyanopindolol (CHEBI:73370) is a secondary amino compound (CHEBI:50995) |
| iproheptine (CHEBI:134804) is a secondary amino compound (CHEBI:50995) |
| Iproheptine hydrochloride (CHEBI:31720) is a secondary amino compound (CHEBI:50995) |
| isometheptene (CHEBI:134765) is a secondary amino compound (CHEBI:50995) |
| isoprenaline (CHEBI:64317) is a secondary amino compound (CHEBI:50995) |
| ketamine (CHEBI:6121) is a secondary amino compound (CHEBI:50995) |
| LDC4297 (CHEBI:144671) is a secondary amino compound (CHEBI:50995) |
| leniolisib (CHEBI:229649) is a secondary amino compound (CHEBI:50995) |
| liproxstatin-1 (CHEBI:173097) is a secondary amino compound (CHEBI:50995) |
| loline (CHEBI:156448) is a secondary amino compound (CHEBI:50995) |
| LRRK2-IN-1 (CHEBI:78413) is a secondary amino compound (CHEBI:50995) |
| lumiracoxib (CHEBI:73044) is a secondary amino compound (CHEBI:50995) |
| LY3009120 (CHEBI:167662) is a secondary amino compound (CHEBI:50995) |
| mannopine (CHEBI:80662) is a secondary amino compound (CHEBI:50995) |
| mansouramycin A (CHEBI:177359) is a secondary amino compound (CHEBI:50995) |
| meclofenamic acid (CHEBI:6710) is a secondary amino compound (CHEBI:50995) |
| mefenamic acid (CHEBI:6717) is a secondary amino compound (CHEBI:50995) |
| mefuparib (CHEBI:167905) is a secondary amino compound (CHEBI:50995) |
| melagatran (CHEBI:43966) is a secondary amino compound (CHEBI:50995) |
| mepanipyrim (CHEBI:6751) is a secondary amino compound (CHEBI:50995) |
| mephedrone (CHEBI:59331) is a secondary amino compound (CHEBI:50995) |
| metachromin S (CHEBI:66695) is a secondary amino compound (CHEBI:50995) |
| methyl N-(2,6-dichlorobenzyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]alaninate (CHEBI:48475) is a secondary amino compound (CHEBI:50995) |
| methyl N-methylanthranilate (CHEBI:142267) is a secondary amino compound (CHEBI:50995) |
| methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate (CHEBI:88206) is a secondary amino compound (CHEBI:50995) |
| methyl 5-(hydroxymethyl)pyrrolidine-2-carboxylate (CHEBI:70834) is a secondary amino compound (CHEBI:50995) |
| methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate (CHEBI:70830) is a secondary amino compound (CHEBI:50995) |
| methyl blue free acid (CHEBI:87477) is a secondary amino compound (CHEBI:50995) |
| methylstat (CHEBI:95078) is a secondary amino compound (CHEBI:50995) |
| metipranolol (CHEBI:6897) is a secondary amino compound (CHEBI:50995) |
| metoprolol (CHEBI:6904) is a secondary amino compound (CHEBI:50995) |
| ML228 (CHEBI:92777) is a secondary amino compound (CHEBI:50995) |
| ML240 (CHEBI:143014) is a secondary amino compound (CHEBI:50995) |
| ML355 (CHEBI:195557) is a secondary amino compound (CHEBI:50995) |
| mocetinostat (CHEBI:197437) is a secondary amino compound (CHEBI:50995) |
| momelotinib (CHEBI:91407) is a secondary amino compound (CHEBI:50995) |
| monomethylphosphatidylethanolamine 36:2 (CHEBI:134488) is a secondary amino compound (CHEBI:50995) |
| MRS4833 (CHEBI:233335) is a secondary amino compound (CHEBI:50995) |
| N-deethylaconine (CHEBI:132643) is a secondary amino compound (CHEBI:50995) |
| N-ethyl-Cyclopentanamine (CHEBI:229339) is a secondary amino compound (CHEBI:50995) |
| N-ethyl-N'-[4-[4-[4-[4-[4-[4-[4-[4-(ethylamino)butylamino]butylamino]butylamino]butylamino]but-2-enylamino]butylamino]butylamino]butyl]butane-1,4-diamine (CHEBI:93761) is a secondary amino compound (CHEBI:50995) |
| N-Methyloctan-1-amine (CHEBI:228566) is a secondary amino compound (CHEBI:50995) |
| N,N'-bis[3-(ethylamino)propyl]-2-butene-1,4-diamine (CHEBI:93760) is a secondary amino compound (CHEBI:50995) |
| navitoclax (CHEBI:131174) is a secondary amino compound (CHEBI:50995) |
| nilotinib (CHEBI:52172) is a secondary amino compound (CHEBI:50995) |
| nirogacestat (CHEBI:229217) is a secondary amino compound (CHEBI:50995) |
| nisoxetine (CHEBI:73410) is a secondary amino compound (CHEBI:50995) |
| nocardicin G (CHEBI:81024) is a secondary amino compound (CHEBI:50995) |
| norajmaline (CHEBI:7621) is a secondary amino compound (CHEBI:50995) |
| norbelladine (CHEBI:80666) is a secondary amino compound (CHEBI:50995) |
| norcocaine (CHEBI:178585) is a secondary amino compound (CHEBI:50995) |
| norflurazon (CHEBI:50842) is a secondary amino compound (CHEBI:50995) |
| noribogaine (CHEBI:146264) is a secondary amino compound (CHEBI:50995) |
| NS-8593 (CHEBI:232985) is a secondary amino compound (CHEBI:50995) |
| NSC 23766 (CHEBI:144984) is a secondary amino compound (CHEBI:50995) |
| octamylamine (CHEBI:134861) is a secondary amino compound (CHEBI:50995) |
| olodaterol (CHEBI:82700) is a secondary amino compound (CHEBI:50995) |
| onosmin A (CHEBI:66821) is a secondary amino compound (CHEBI:50995) |
| onosmin B (CHEBI:66822) is a secondary amino compound (CHEBI:50995) |
| osimertinib (CHEBI:90943) is a secondary amino compound (CHEBI:50995) |
| PA-16-0081C (CHEBI:144673) is a secondary amino compound (CHEBI:50995) |
| PABA/NO (CHEBI:195533) is a secondary amino compound (CHEBI:50995) |
| pacein (CHEBI:90290) is a secondary amino compound (CHEBI:50995) |
| palbociclib (CHEBI:85993) is a secondary amino compound (CHEBI:50995) |
| pamapimod (CHEBI:90685) is a secondary amino compound (CHEBI:50995) |
| panobinostat (CHEBI:85990) is a secondary amino compound (CHEBI:50995) |
| pavettamine (CHEBI:178009) is a secondary amino compound (CHEBI:50995) |
| PD 0325901 (CHEBI:88249) is a secondary amino compound (CHEBI:50995) |
| PD-153035 (CHEBI:91076) is a secondary amino compound (CHEBI:50995) |
| PD158780 (CHEBI:92843) is a secondary amino compound (CHEBI:50995) |
| pendimethalin (CHEBI:83569) is a secondary amino compound (CHEBI:50995) |
| pevonedistat (CHEBI:145535) is a secondary amino compound (CHEBI:50995) |
| pexidartinib (CHEBI:145373) is a secondary amino compound (CHEBI:50995) |
| PF-3758309 (CHEBI:93751) is a secondary amino compound (CHEBI:50995) |
| PF-573228 (CHEBI:91446) is a secondary amino compound (CHEBI:50995) |
| PFE-PKIS 18 (CHEBI:144783) is a secondary amino compound (CHEBI:50995) |
| phenylephrine (CHEBI:8093) is a secondary amino compound (CHEBI:50995) |
| pibutidine (CHEBI:145662) is a secondary amino compound (CHEBI:50995) |
| plerixafor (CHEBI:125354) is a secondary amino compound (CHEBI:50995) |
| PLS-123 (CHEBI:230531) is a secondary amino compound (CHEBI:50995) |
| poziotinib (CHEBI:195559) is a secondary amino compound (CHEBI:50995) |
| practolol (CHEBI:258351) is a secondary amino compound (CHEBI:50995) |
| praliciguat (CHEBI:142431) is a secondary amino compound (CHEBI:50995) |
| propafenone (CHEBI:63619) is a secondary amino compound (CHEBI:50995) |
| propylhexedrine (CHEBI:134783) is a secondary amino compound (CHEBI:50995) |
| pseudoephedrine (CHEBI:51209) is a secondary amino compound (CHEBI:50995) |
| purmorphamine (CHEBI:63053) is a secondary amino compound (CHEBI:50995) |
| pyrimethanil (CHEBI:8674) is a secondary amino compound (CHEBI:50995) |
| pyriminostrobin (CHEBI:142826) is a secondary amino compound (CHEBI:50995) |
| quinaminoprole (CHEBI:233600) is a secondary amino compound (CHEBI:50995) |
| quisinostat (CHEBI:94771) is a secondary amino compound (CHEBI:50995) |
| R24 (CHEBI:79310) is a secondary amino compound (CHEBI:50995) |
| retaspimycin (CHEBI:71975) is a secondary amino compound (CHEBI:50995) |
| reversine (CHEBI:70723) is a secondary amino compound (CHEBI:50995) |
| ritlecitinib (CHEBI:229233) is a secondary amino compound (CHEBI:50995) |
| robenacoxib (CHEBI:76269) is a secondary amino compound (CHEBI:50995) |
| rucaparib (CHEBI:134689) is a secondary amino compound (CHEBI:50995) |
| ryuvidine (CHEBI:92119) is a secondary amino compound (CHEBI:50995) |
| salumycin (CHEBI:177360) is a secondary amino compound (CHEBI:50995) |
| sapitinib (CHEBI:132986) is a secondary amino compound (CHEBI:50995) |
| saracatinib (CHEBI:47458) is a secondary amino compound (CHEBI:50995) |
| sarpagine (CHEBI:9036) is a secondary amino compound (CHEBI:50995) |
| SB 415286 (CHEBI:91107) is a secondary amino compound (CHEBI:50995) |
| SCH-79797 (CHEBI:94998) is a secondary amino compound (CHEBI:50995) |
| SCH51344 (CHEBI:77556) is a secondary amino compound (CHEBI:50995) |
| secodine (CHEBI:146250) is a secondary amino compound (CHEBI:50995) |
| secondary amine (CHEBI:32863) is a secondary amino compound (CHEBI:50995) |
| selumetinib (CHEBI:90227) is a secondary amino compound (CHEBI:50995) |
| sertraline (CHEBI:9123) is a secondary amino compound (CHEBI:50995) |
| SGC-CK2-1 (CHEBI:156441) is a secondary amino compound (CHEBI:50995) |
| SGC-CLK-1 (CHEBI:156443) is a secondary amino compound (CHEBI:50995) |
| SMER 28 (CHEBI:93943) is a secondary amino compound (CHEBI:50995) |
| solabegron (CHEBI:141346) is a secondary amino compound (CHEBI:50995) |
| sotalol (CHEBI:63622) is a secondary amino compound (CHEBI:50995) |
| spectinomycin (CHEBI:9215) is a secondary amino compound (CHEBI:50995) |
| spirapril (CHEBI:135756) is a secondary amino compound (CHEBI:50995) |
| spiraprilat (CHEBI:141522) is a secondary amino compound (CHEBI:50995) |
| spirit blue base (CHEBI:86491) is a secondary amino compound (CHEBI:50995) |
| Src Inhibitor-1 (CHEBI:78332) is a secondary amino compound (CHEBI:50995) |
| Src Inhibitor-5 (CHEBI:78344) is a secondary amino compound (CHEBI:50995) |
| SRS11-92 (CHEBI:173095) is a secondary amino compound (CHEBI:50995) |
| SRS16-86 (CHEBI:173096) is a secondary amino compound (CHEBI:50995) |
| stepharine (CHEBI:132715) is a secondary amino compound (CHEBI:50995) |
| STM2457 (CHEBI:172325) is a secondary amino compound (CHEBI:50995) |
| suloctidil (CHEBI:91639) is a secondary amino compound (CHEBI:50995) |
| TAK-733 (CHEBI:231366) is a secondary amino compound (CHEBI:50995) |
| tanespimycin (CHEBI:64153) is a secondary amino compound (CHEBI:50995) |
| terpendole J (CHEBI:66209) is a secondary amino compound (CHEBI:50995) |
| tesevatinib (CHEBI:167674) is a secondary amino compound (CHEBI:50995) |
| texazone (CHEBI:197442) is a secondary amino compound (CHEBI:50995) |
| TG101209 (CHEBI:90304) is a secondary amino compound (CHEBI:50995) |
| thalicpureine (CHEBI:143869) is a secondary amino compound (CHEBI:50995) |
| thiamet G (CHEBI:233586) is a secondary amino compound (CHEBI:50995) |
| THZ531 (CHEBI:143122) is a secondary amino compound (CHEBI:50995) |
| ticagrelor (CHEBI:68558) is a secondary amino compound (CHEBI:50995) |
| TMC-52A (CHEBI:66238) is a secondary amino compound (CHEBI:50995) |
| TMC-52B (CHEBI:66239) is a secondary amino compound (CHEBI:50995) |
| TMC-52C (CHEBI:66240) is a secondary amino compound (CHEBI:50995) |
| TMC-52D (CHEBI:66241) is a secondary amino compound (CHEBI:50995) |
| tolfenamic acid (CHEBI:32243) is a secondary amino compound (CHEBI:50995) |
| torasemide (CHEBI:9637) is a secondary amino compound (CHEBI:50995) |
| torasemide carboxylic acid (CHEBI:155916) is a secondary amino compound (CHEBI:50995) |
| trandolapril (CHEBI:9649) is a secondary amino compound (CHEBI:50995) |
| trandolaprilat (CHEBI:141521) is a secondary amino compound (CHEBI:50995) |
| Trientine hydrochloride (CHEBI:9706) is a secondary amino compound (CHEBI:50995) |
| TRODAT-1 (CHEBI:234467) is a secondary amino compound (CHEBI:50995) |
| tubulosine (CHEBI:9775) is a secondary amino compound (CHEBI:50995) |
| UCL 1684 (CHEBI:35040) is a secondary amino compound (CHEBI:50995) |
| ulotaront (CHEBI:228346) is a secondary amino compound (CHEBI:50995) |
| UNC0638 (CHEBI:95074) is a secondary amino compound (CHEBI:50995) |
| UNC0642 (CHEBI:233643) is a secondary amino compound (CHEBI:50995) |
| validamycin A (CHEBI:29703) is a secondary amino compound (CHEBI:50995) |
| validamycin B (CHEBI:90868) is a secondary amino compound (CHEBI:50995) |
| validoxylamine A (CHEBI:131941) is a secondary amino compound (CHEBI:50995) |
| validoxylamine A 7'-phosphate (CHEBI:131938) is a secondary amino compound (CHEBI:50995) |
| validoxylamine B (CHEBI:141057) is a secondary amino compound (CHEBI:50995) |
| varenicline (CHEBI:84500) is a secondary amino compound (CHEBI:50995) |
| varlitinib (CHEBI:231356) is a secondary amino compound (CHEBI:50995) |
| vatalanib (CHEBI:90620) is a secondary amino compound (CHEBI:50995) |
| vilanterol (CHEBI:75037) is a secondary amino compound (CHEBI:50995) |
| volasertib (CHEBI:231358) is a secondary amino compound (CHEBI:50995) |
| vosaroxin (CHEBI:231651) is a secondary amino compound (CHEBI:50995) |
| WAY-316606 (CHEBI:140700) is a secondary amino compound (CHEBI:50995) |
| ximelagatran (CHEBI:65172) is a secondary amino compound (CHEBI:50995) |
| XMD-17-51 (CHEBI:234455) is a secondary amino compound (CHEBI:50995) |
| XMU-MP-1 (CHEBI:231615) is a secondary amino compound (CHEBI:50995) |
| xylazine (CHEBI:92386) is a secondary amino compound (CHEBI:50995) |
| zinolol (CHEBI:66506) is a secondary amino compound (CHEBI:50995) |
| ZM 323881 (CHEBI:91185) is a secondary amino compound (CHEBI:50995) |
| ZM447439 (CHEBI:91376) is a secondary amino compound (CHEBI:50995) |
| α-(methylamino)isobutyric acid (CHEBI:134261) is a secondary amino compound (CHEBI:50995) |
| α-putrescinylthymine (CHEBI:132931) is a secondary amino compound (CHEBI:50995) |
